{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:14:00Z","timestamp":1790615640785,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"L\u2019Or\u00e9al Dermatological Beauty"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s13555-025-01628-3","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T13:25:50Z","timestamp":1766496350000},"page":"1055-1064","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the Efficacy of a 2-MNG-Containing Serum on Improving Skin Tone and Hyperpigmentation"],"prefix":"10.1007","volume":"16","author":[{"given":"Rui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zailing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kungchi","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shermine","family":"Warde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Kerob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9043-144X","authenticated-orcid":false,"given":"Yijie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"1628_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.det.2023.02.005","volume":"41","author":"NC Syder","year":"2023","unstructured":"Syder NC, Quarshie C, Elbuluk N. Disorders of facial hyperpigmentation. Dermatol Clin. 2023;41:393\u2013405. https:\/\/doi.org\/10.1016\/j.det.2023.02.005.","journal-title":"Dermatol Clin"},{"key":"1628_CR2","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1001\/jamadermatol.2023.1414","volume":"159","author":"RV Kundu","year":"2023","unstructured":"Kundu RV, Aderibigbe O, Riley JM. Managing facial hyperpigmentation. JAMA Dermatol. 2023;159:778\u20139. https:\/\/doi.org\/10.1001\/jamadermatol.2023.1414.","journal-title":"JAMA Dermatol"},{"key":"1628_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14095","volume":"33","author":"T Searle","year":"2020","unstructured":"Searle T, Al-Niaimi F, Ali FR. The top 10 cosmeceuticals for facial hyperpigmentation. Dermatol Ther. 2020;33:e14095. https:\/\/doi.org\/10.1111\/dth.14095.","journal-title":"Dermatol Ther"},{"key":"1628_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2165\/00128071-200001050-00001","volume":"1","author":"A P\u00e9rez-Bernal","year":"2000","unstructured":"P\u00e9rez-Bernal A, Mu\u00f1oz-P\u00e9rez MA, Camacho F. Management of facial hyperpigmentation. Am J Clin Dermatol. 2000;1:261\u20138. https:\/\/doi.org\/10.2165\/00128071-200001050-00001.","journal-title":"Am J Clin Dermatol"},{"key":"1628_CR5","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1080\/09546634.2021.1914313","volume":"33","author":"N Neagu","year":"2022","unstructured":"Neagu N, et al. Melasma treatment: a systematic review. J Dermatolog Treat. 2022;33:1816\u201337. https:\/\/doi.org\/10.1080\/09546634.2021.1914313.","journal-title":"J Dermatolog Treat"},{"key":"1628_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.sder.2012.02.002","volume":"31","author":"AN Kauvar","year":"2012","unstructured":"Kauvar AN. The evolution of melasma therapy: targeting melanosomes using low-fluence Q-switched neodymium-doped yttrium aluminium garnet lasers. Semin Cutan Med Surg. 2012;31:126\u201332. https:\/\/doi.org\/10.1016\/j.sder.2012.02.002.","journal-title":"Semin Cutan Med Surg"},{"key":"1628_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40257-016-0239-8","volume":"18","author":"NA Vashi","year":"2017","unstructured":"Vashi NA, Wirya SA, Inyang M, Kundu RV. Facial hyperpigmentation in skin of color: special considerations and treatment. Am J Clin Dermatol. 2017;18:215\u201330. https:\/\/doi.org\/10.1007\/s40257-016-0239-8.","journal-title":"Am J Clin Dermatol"},{"key":"1628_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s0733-8635(05)70150-9","volume":"18","author":"AG Pandya","year":"2000","unstructured":"Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol Clin. 2000;18:91\u20138. https:\/\/doi.org\/10.1016\/s0733-8635(05)70150-9.","journal-title":"Dermatol Clin"},{"key":"1628_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1923","volume":"7","author":"X Zhang","year":"2024","unstructured":"Zhang X, et al. Evaluation of the efficacy of a sunscreen containing ultra-long UVA1 and other UVR broad-spectrum filters on skin barrier protection and melanin content reduction in Chinese adults: a single-center study. Health Sci Rep. 2024;7:e1923. https:\/\/doi.org\/10.1002\/hsr2.1923.","journal-title":"Health Sci Rep"},{"key":"1628_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/srt.12589","volume":"25","author":"R Cabrera-Alonso","year":"2019","unstructured":"Cabrera-Alonso R, Guevara E, Ram\u00edrez-El\u00edas MG, Moncada B, Gonz\u00e1lez FJ. Detection of hydroquinone by Raman spectroscopy in patients with melasma before and after treatment. Skin Res Technol. 2019;25:20\u20134. https:\/\/doi.org\/10.1111\/srt.12589.","journal-title":"Skin Res Technol"},{"key":"1628_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40257-021-00643-2","volume":"23","author":"VD Callender","year":"2022","unstructured":"Callender VD, et al. Effects of topical retinoids on acne and post-inflammatory hyperpigmentation in patients with skin of color: a clinical review and implications for practice. Am J Clin Dermatol. 2022;23:69\u201381. https:\/\/doi.org\/10.1007\/s40257-021-00643-2.","journal-title":"Am J Clin Dermatol"},{"key":"1628_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1473-2165.2007.00321.x","volume":"6","author":"D Rigopoulos","year":"2007","unstructured":"Rigopoulos D, Gregoriou S, Katsambas A. Hyperpigmentation and melasma. J Cosmet Dermatol. 2007;6:195\u2013202. https:\/\/doi.org\/10.1111\/j.1473-2165.2007.00321.x.","journal-title":"J Cosmet Dermatol"},{"key":"1628_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/ijd.17522","volume":"64","author":"J Ocampo-Candiani","year":"2025","unstructured":"Ocampo-Candiani J, et al. Latin American consensus on the treatment of melasma. Int J Dermatol. 2025;64:499\u2013512. https:\/\/doi.org\/10.1111\/ijd.17522.","journal-title":"Int J Dermatol"},{"key":"1628_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1046\/j.1365-2133.2002.04834.x","volume":"147","author":"T Hakozaki","year":"2002","unstructured":"Hakozaki T, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147:20\u201331. https:\/\/doi.org\/10.1046\/j.1365-2133.2002.04834.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1628_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/bjd.12536","volume":"169","author":"NA Vashi","year":"2013","unstructured":"Vashi NA, Kundu RV. Facial hyperpigmentation: causes and treatment. Br J Dermatol. 2013;169(3):41\u201356. https:\/\/doi.org\/10.1111\/bjd.12536.","journal-title":"Br J Dermatol"},{"key":"1628_CR16","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2021-11-2","author":"S Moolla","year":"2022","unstructured":"Moolla S, Miller-Monthrope Y. Dermatology: how to manage facial hyperpigmentation in skin of colour. Drugs Context. 2022. https:\/\/doi.org\/10.7573\/dic.2021-11-2.","journal-title":"Drugs Context"},{"key":"1628_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/cod.14793","volume":"93","author":"L Vernhet","year":"2025","unstructured":"Vernhet L, et al. First two cases of allergic contact dermatitis from isobutylamido thiazolyl resorcinol (\u2018Thiamidol\u2019) in depigmenting skin care routine. Contact Dermatitis. 2025;93:63\u20135. https:\/\/doi.org\/10.1111\/cod.14793.","journal-title":"Contact Dermatitis"},{"key":"1628_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16735","volume":"24","author":"AL Demessant-Flavigny","year":"2025","unstructured":"Demessant-Flavigny AL, et al. Efficacy of a 2-MNG-containing depigmenting serum in the treatment of post-inflammatory hyperpigmentation. J Cosmet Dermatol. 2025;24:e16735. https:\/\/doi.org\/10.1111\/jocd.16735.","journal-title":"J Cosmet Dermatol"},{"key":"1628_CR19","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/jdv.19910","volume":"38","author":"B Muller","year":"2024","unstructured":"Muller B, et al. A bayesian network meta-analysis of 14 molecules inhibiting UV daylight-induced pigmentation. J Eur Acad Dermatol Venereol. 2024;38:1566\u201374. https:\/\/doi.org\/10.1111\/jdv.19910.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1628_CR20","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1111\/jocd.16200","volume":"23","author":"R de Dormael","year":"2024","unstructured":"de Dormael R, et al. 2-mercaptonicotinoyl glycine prevents UV-induced skin darkening and delayed tanning in healthy subjects: a randomized controlled clinical study. J Cosmet Dermatol. 2024;23:1745\u201352. https:\/\/doi.org\/10.1111\/jocd.16200.","journal-title":"J Cosmet Dermatol"},{"key":"1628_CR21","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/pcmr.13168","volume":"37","author":"P Sextius","year":"2024","unstructured":"Sextius P, et al. 2-Mercaptonicotinoyl glycine, a new potent melanogenesis inhibitor, exhibits a unique mode of action while preserving melanocyte integrity. Pigment Cell Melanoma Res. 2024;37:462\u201379. https:\/\/doi.org\/10.1111\/pcmr.13168.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1628_CR22","doi-asserted-by":"publisher","first-page":"1278838","DOI":"10.3389\/fphar.2023.1278838","volume":"14","author":"P Shu","year":"2023","unstructured":"Shu P, et al. Efficacy and mechanism of retinyl palmitate against UVB-induced skin photoaging. Front Pharmacol. 2023;14:1278838. https:\/\/doi.org\/10.3389\/fphar.2023.1278838.","journal-title":"Front Pharmacol"},{"key":"1628_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000359974","volume":"27","author":"J Wohlrab","year":"2014","unstructured":"Wohlrab J, Kreft D. Niacinamide\u2014Mechanisms of action and its topical use in dermatology. Skin Pharmacol Physiol. 2014;27:311\u20135. https:\/\/doi.org\/10.1159\/000359974.","journal-title":"Skin Pharmacol Physiol"},{"key":"1628_CR24","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s13555-025-01473-4","volume":"15","author":"T Passeron","year":"2025","unstructured":"Passeron T, et al. Efficacy and tolerability of a new facial 2-mercaptonicotinoyl glycine-containing depigmenting serum versus hydroquinone 4% over 3-month treatment of facial melasma. Dermatol Ther (Heidelb). 2025;15:2379\u201390. https:\/\/doi.org\/10.1007\/s13555-025-01473-4.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1628_CR25","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1111\/jocd.14382","volume":"20","author":"O Artzi","year":"2021","unstructured":"Artzi O, et al. The pathogenesis of melasma and implications for treatment. J Cosmet Dermatol. 2021;20:3432\u201345. https:\/\/doi.org\/10.1111\/jocd.14382.","journal-title":"J Cosmet Dermatol"},{"key":"1628_CR26","first-page":"1","volume":"21","author":"B Sofen","year":"2016","unstructured":"Sofen B, Prado G, Emer J. Melasma and post inflammatory hyperpigmentation: management update and expert opinion. Skin Ther Lett. 2016;21:1\u20137.","journal-title":"Skin Ther Lett"},{"key":"1628_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40257-019-00488-w","volume":"21","author":"J McKesey","year":"2020","unstructured":"McKesey J, Tovar-Garza A, Pandya AG. Melasma treatment: an evidence-based review. Am J Clin Dermatol. 2020;21:173\u2013225. https:\/\/doi.org\/10.1007\/s40257-019-00488-w.","journal-title":"Am J Clin Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01628-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01628-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01628-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:41:15Z","timestamp":1772001675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01628-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1628"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01628-3","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Rui Li, Baiyu Li, Yang Chen, Huijuan Liu, Qilin Zhang and Yijie Zheng are full-time employees of\u00a0L\u2019Or\u00e9al Dermatological Beauty, Shanghai, China. Xiaofeng He, Shuting Li, Zailing Zhu, Xiaoyin Zhou, Kungchi Hsu and Yueqing Niu are full-time employees of Research and Innovation Center, L\u2019Or\u00e9al China, Shanghai, China. Claire Huguet and Wei Xiong are full-time employees of North Asia L\u2019Or\u00e9al Dermatological Beauty, L\u2019Or\u00e9al North Asia, Shanghai, China. Shermine Warde and Delphine Kerob are full-time employees of La Roche-Posay Laboratoire Dermatologique, Levallois Perret, La Roche-Posay, France.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki of 1964 and its subsequent amendments and followed the OECD Good Clinical Practice (GCP) guidelines. The study was approved by the SGS Clinical Research Ethics Committee (No. SS-2024-001S, 2024022). Written informed consent to participate in the study and for publication was provided by all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}